Baseline patient and operative characteristics | Study cohort (n = 541,353) |
---|---|
Age | |
18 to 19 years | 185 (0%) |
20 to 24 years | 713 (0.1%) |
25 to 29 years | 1274 (0.2%) |
30 to 34 years | 2149 (0.4%) |
35 to 39 years | 4214 (0.8%) |
40 to 44 years | 8927 (1.6%) |
45 to 49 years | 19,830 (3.7%) |
50 to 54 years | 41,043 (7.6%) |
55 to 59 years | 66,534 (12.3%) |
60 to 64 years | 85,568 (15.8%) |
65 to 69 years | 91,048 (16.8%) |
70 to 74 years | 122,581 (22.6%) |
75 to 79 years | 93,717 (17.3%) |
80 to 84 years | 3570 (0.7%) |
Male sex | 234,875 (43.4%) |
Obesity | 109,291 (20.2%) |
Pre-operative opioid use | |
One pre-op opioid prescription | 79,174 (14.6%) |
Two or more pre-op opioid prescriptions | 126,792 (23.4%) |
Charlson comorbidity index | |
CCI 0 | 289,815 (53.5%) |
CCI 1 | 109,118 (20.2%) |
CCI 2 | 62,630 (11.6%) |
CCI 3 | 34,447 (6.4%) |
CCI 4 | 17,597 (3.3%) |
CCI 5 or more | 27,746 (5.1%) |
Mean CCI (SD) | 1.1 (1.77) |
Year | |
2010 | 21,718 (4%) |
2011 | 61,833 (11.4%) |
2012 | 66,077 (12.2%) |
2013 | 70,591 (13%) |
2014 | 75,123 (13.9%) |
2015 | 74,112 (13.7%) |
2016 | 73,574 (13.6%) |
2017 | 69,798 (12.9%) |
2018 | 28,514 (5.3%) |